New oral anticoagulants for atrial fibrillation: The factor Xa inhibitors rivaroxaban and apixaban

Russell S. Roberson, Andrew D. Shaw

Research output: Contribution to journalArticle

Original languageEnglish (US)
JournalReviews in Cardiovascular Medicine
Volume13
Issue number1
DOIs
StatePublished - 2012

Fingerprint

Anticoagulants
Atrial Fibrillation
Rivaroxaban
Factor Xa Inhibitors
apixaban

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

New oral anticoagulants for atrial fibrillation : The factor Xa inhibitors rivaroxaban and apixaban. / Roberson, Russell S.; Shaw, Andrew D.

In: Reviews in Cardiovascular Medicine, Vol. 13, No. 1, 2012.

Research output: Contribution to journalArticle

@article{89cdd4be06ee4b41a2b21dff7eb18657,
title = "New oral anticoagulants for atrial fibrillation: The factor Xa inhibitors rivaroxaban and apixaban",
author = "Roberson, {Russell S.} and Shaw, {Andrew D.}",
year = "2012",
doi = "10.3909/ricm0642",
language = "English (US)",
volume = "13",
journal = "Reviews in Cardiovascular Medicine",
issn = "1530-6550",
publisher = "MedReviews LLC",
number = "1",

}

TY - JOUR

T1 - New oral anticoagulants for atrial fibrillation

T2 - The factor Xa inhibitors rivaroxaban and apixaban

AU - Roberson, Russell S.

AU - Shaw, Andrew D.

PY - 2012

Y1 - 2012

UR - http://www.scopus.com/inward/record.url?scp=84863093673&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863093673&partnerID=8YFLogxK

U2 - 10.3909/ricm0642

DO - 10.3909/ricm0642

M3 - Article

C2 - 22565540

AN - SCOPUS:84863093673

VL - 13

JO - Reviews in Cardiovascular Medicine

JF - Reviews in Cardiovascular Medicine

SN - 1530-6550

IS - 1

ER -